AstraZeneca vs Reply

AstraZeneca (Data and AI: Unlocking new science insights) and Reply (AI sales engagement for email, LinkedIn, SMS & calls. Open APIs, SDKs, and MCP server for developers building on Reply. Builders of Jason, the AI SDR.) both appear on the Smoower Developer Ecosystem Index.

AstraZeneca (rank #510) holds a narrow lead over Reply (rank #662) on the overall Smoower ecosystem score (37 vs 32). The gap of 5 points reflects composite signals across code, docs, community and reach.

On code quality (the state of repositories, tests, releases and polish), AstraZeneca is clearly ahead of Reply. On education (docs, guides and learning material for developers), AstraZeneca is slightly ahead of Reply. On community (issue response, PR reviews and discussion health), AstraZeneca is ahead of Reply. On reach (how visible the ecosystem is beyond its own repos), AstraZeneca is ahead of Reply. On momentum (release cadence and how fast the ecosystem moves), Reply is clearly ahead of AstraZeneca.

AstraZeneca carries 5,180 GitHub stars across 107 public repos, with 22 repositories active in the last 90 days and 2 external contributors on record. Reply shows 0 stars across 3 public repos, 2 active in the last 90 days and 0 external contributors.

AstraZeneca is the stronger read for anyone weighting code quality. Reply looks better where momentum is the deciding factor. The table below breaks the scores down pillar by pillar; the linked profiles cover the underlying repos, docs and community signals in full.